Cell Culture Protein Surface Coating Global Market Report 2024

Cell culture protein surface coating involves the application of specific proteins or biomolecules onto the surfaces of culture vessels such as Petri dishes, flasks, or plates. The goal is to improve cell attachment, growth, and behavior in an in vitro setting, simulating the natural extracellular matrix (ECM) encountered by cells in vivo. This coating enhances cell adhesion, development, and differentiation, which are critical for biomedical and research purposes.

The primary types of cell culture protein surface coating include pre-coating, which involves applying coatings before using the surfaces. Protein sources used for coating include animal-derived, human-derived, synthetic, and plant-derived proteins, applied in scientific research and industrial production contexts.

The cell culture protein surface coating market research report is one of a series of new reports that provides cell culture protein surface coating market statistics, including cell culture protein surface coating industry global market size, regional shares, competitors with a cell culture protein surface coating market share, detailed cell culture protein surface coating market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture protein surface coating industry. This cell culture protein surface coating market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell culture protein surface coating market has grown rapidly in recent years. It will grow from $0.89 billion in 2023 to $1.03 billion in 2024 at a compound annual growth rate (CAGR) of 15.2%. Historical growth can be credited to heightened emphasis on stem cell research, increasing incidence of chronic diseases, and growing interest in cell-based research.

The cell culture protein surface coating market is expected to see rapid growth in the next few years. It will grow to $1.83 billion in 2028 at a compound annual growth rate (CAGR) of 15.6%. Projected growth is anticipated due to the expanding adoption of 3D cell culture, rising demand for protein therapeutics, increased healthcare expenditure, and enhanced investments in research and development. Key trends in the forecast period include advancements in high-throughput screening techniques, technological developments, and significant launches of new products and services.

The rising demand for biopharmaceutical products is anticipated to drive the growth of the cell culture protein surface coating market in the future. Biopharmaceutical products, which include medicinal products derived from living organisms or produced using biotechnological processes such as recombinant DNA technology, cell cultures, and monoclonal antibodies, are increasingly in demand. This surge is attributed to cell culture technologies, the rise in chronic diseases, the occurrence of age-related diseases, innovations in bioprocessing, and advancements in genomics. Cell culture protein surface coatings enhance cell growth, functionality, and production efficiency in biopharmaceutical manufacturing, contributing to the development of safe, effective, and high-quality biopharmaceutical products. For example, according to a report by the Alliance for Regenerative Medicine in August 2023, there were 2,760 cell, gene, and tissue-engineering therapeutic developers globally in the first quarter of 2023, an increase of 101% from 1,369 in the first quarter of 2022. Hence, the rising demand for biopharmaceutical products is propelling the growth of the cell culture protein surface coating market.

The increasing prevalence of chronic diseases is expected to fuel the growth of the cell culture protein surface coating market. Chronic diseases are long-lasting conditions that typically require ongoing medical attention and can limit daily activities or quality of life. Factors such as altered habits, inheritance, and exposure to chemicals, toxins, and pollutants contribute to the prevalence of chronic diseases. Cell culture protein surface coatings are crucial in chronic disease research, offering a robust platform for investigating disease mechanisms, screening drugs, and developing innovative therapeutic strategies. For instance, in January 2023, the National Center for Biotechnology Information (NCBI) reported that the number of people aged 50 and above suffering from one or more chronic illnesses is expected to rise by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Therefore, the increased prevalence of chronic diseases is driving the growth of the cell culture protein surface coating market.

In January 2022, Thermo Fisher Scientific Inc., a U.S.-based biotechnology company, acquired PeproTech, Inc. for an undisclosed amount. This acquisition aims to enhance Thermo Fisher Scientific's capabilities in providing high-quality recombinant proteins, including cytokines and growth factors, by strengthening its portfolio to support cell growth, expansion, and biopharmaceutical development. PeproTech Inc. is a U.S. company that produces a wide range of products supporting cell growth and expansion.

Major companies operating in the cell culture protein surface coating market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Avantor Inc., Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Greiner AG, Eppendorf SE, Bio-Techne Corporation, Promega Corporation, ReproCELL Inc., MoBiTec GmbH, Advanced Biomatrix Inc., AMS Biotechnology (Europe) Limited, Cell Guidance Systems, Kollodis BioSciences Inc., NeuVitro Corporation, ZenBio Inc., SPL Life Sciences Co. Ltd.

North America was the largest region in the cell culture protein surface coating market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell culture protein surface coating market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell culture protein surface coating market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell culture protein surface coating market consists of revenues earned by entities by providing services such as promoting cell attachment, aiding cell growth, guiding cell differentiation, and maintaining cell functionality. These services are used in various applications including drug discovery, genomics, clinical diagnostics, and other research and development activities. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell culture protein surface coating market also includes fibronectin, collagen, laminin, gelatin, poly-L/D-lysine, BSA, and Matrigel. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.